Rx Import Status In Senate Judiciary Committee Could Shift Under Specter
This article was originally published in The Pink Sheet Daily
Executive Summary
Outgoing Judiciary Chairman Hatch (R-Utah) used hearings on importation to point out legal problems. His likely successor, Sen. Specter (R-Penn.), is a cosponsor of Rx import legislation.
You may also be interested in...
"BioShield II" Hearing Reveals Continued Division On IP Incentives
GPhA should provide more input on its concerns over intellectual property protections in the bill, Sen. Enzi says. Though R&D incentives are needed, a "wild card" exclusivity provision could allow unfair patent extensions, Sen. Schumer argues.
Rx Import Bills Do Not Have Adequate Funding For FDA, Agency Says
Senate bills "do not go far enough" in allowing FDA to assure safety and efficacy of imported drugs, FDA's Hubbard tells Judiciary Committee hearing. Senate Health Committee will mark up Sen. Gregg's import bill July 21.
GSK's Nucala Is Significantly Overpriced, ICER Draft Report Finds
New biologic for severe asthma doesn't stack up well to standard of care on generally accepted levels of cost per quality-adjusted life year.